Trade AbbVie ^ABBV

AbbVie (NYSE:ABBV) Trading 1.1% Higher - Still a Buy?

Citizens Financial Group Inc. RI Raises Holdings in AbbVie Inc. (NYSE:ABBV)

Cornerstone Advisors LLC Boosts Stake in AbbVie Inc. (NYSE:ABBV)

King Luther Capital Management Corp Trims Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) is HealthInvest Partners AB's 7th Largest Position

Banco Santander S.A. Has $12.75 Million Holdings in AbbVie Inc. (NYSE:ABBV)

Mizuho Securities USA LLC Sells 21,611 Shares of AbbVie Inc. (NYSE:ABBV)

LPL Financial LLC Acquires 92,492 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Intech Investment Management LLC

Advisors Asset Management Inc. Lowers Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Stock Price Up 0.1% Following Analyst Upgrade

Altman Advisors Inc. Boosts Holdings in AbbVie Inc. (NYSE:ABBV)

Advisors Asset Management Inc. Sells 39,044 Shares of AbbVie Inc. (NYSE:ABBV)

Howe & Rusling Inc. Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Jennison Associates LLC Purchases 145,542 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie’s Ovarian Cancer drug ‘ELAHERE’ receives marketing approval in Europe

Goldman Sachs maintains sell on Alector, target $4 amid Alzheimer's study By Investing.com

AbbVie (NYSE:ABBV) Trading Down 0.7% - Here's What Happened

AbbVie Inc. (NYSE:ABBV) is Aberdeen Wealth Management LLC’s 10th Largest Position

Princeton Capital Management LLC Cuts Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Banque Cantonale Vaudoise

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Avior Wealth Management LLC

Counterweight Ventures LLC Raises Position in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Price Target Raised to $195.00 at Wells Fargo & Company

MidAtlantic Capital Management Inc. Acquires Shares of 200 AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Position Increased by Windle Wealth LLC

Banque Cantonale Vaudoise Purchases 4,650 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Beddow Capital Management Inc.

Fifth Third Wealth Advisors LLC Raises Stake in AbbVie Inc. (NYSE:ABBV)

Meeder Asset Management Inc. Raises Position in AbbVie Inc. (NYSE:ABBV)

Caprock Group LLC Grows Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Acquired by Quest Partners LLC

Thrivent Financial for Lutherans Boosts Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Short Interest Up 12.1% in October

ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap - November 19, 2024 - Zacks.com

AbbVie (NYSE:ABBV) Trading Up 0.2% - Time to Buy?

Aldeyra Therapeutics Says FDA Accepts NDA For Reproxalap In Dry Eye Disease

GLOBALT Investments LLC GA Invests $3.78 Million in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Bought by Richard C. Young & CO. LTD.

AbbVie Inc. (NYSE:ABBV) Shares Sold by MAI Capital Management

AbbVie Inc. (NYSE:ABBV) Shares Sold by AMG National Trust Bank

Aljian Capital Management LLC Invests $1.33 Million in AbbVie Inc. (NYSE:ABBV)

AbbVie Announces Winners of Inaugural Migraine Experience Contest

European Commission Approves AbbVie's ELAHERE For Platinum-Resistant Ovarian Cancer Treatment

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement By Investing.com

FDA reviews Aldeyra's dry eye disease drug candidate By Investing.com

AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe - November 18, 2024 - Zacks.com

AbbVie Receives European Commission Approval of ELAHERE ® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer By Investing.com

5,060 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Atlanta Consulting Group Advisors LLC

Mizuho Securities USA LLC Reduces Position in AbbVie Inc. (NYSE:ABBV)

Mizuho Markets Americas LLC Decreases Stock Holdings in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Coastline Trust Co

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Seelaus Asset Management LLC

Morgan Stanley Lowers AbbVie (NYSE:ABBV) Price Target to $224.00

AbbVie (NYSE:ABBV) Price Target Lowered to $208.00 at BMO Capital Markets

Symbol: ABBV Security name: AbbVie CDR (CAD Hedged) Status:

AbbVie (NYSE:ABBV) Shares Down 1.7% – Should You Sell?

AbbVie (NYSE:ABBV) Shares Down 1.7% - Should You Sell?

Dearborn Partners LLC Sells 5,410 Shares of AbbVie Inc. (NYSE:ABBV)

Birchcreek Wealth Management LLC Cuts Stock Position in AbbVie Inc. (NYSE:ABBV)

King Wealth Management Group Cuts Position in AbbVie Inc. (NYSE:ABBV)

Simplify Asset Management Inc. Makes New $9.33 Million Investment in AbbVie Inc. (NYSE:ABBV)

AbbVie on Track for Longest Losing Streak Since September 2016 — Data Talk | Morningstar

Simplify Asset Management Inc. Takes Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Empowered Funds LLC

AbbVie (NYSE:ABBV) Now Covered by Analysts at Wolfe Research

CIBC Asset Management Inc Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Intellectus Partners LLC Decreases Stock Position in AbbVie Inc. (NYSE:ABBV)

OneDigital Investment Advisors LLC Decreases Position in AbbVie Inc. (NYSE:ABBV)

William Blair Has Optimistic Outlook of AbbVie Q4 Earnings

Profits drop at Botox plant in Westport as revenues down by 4pc

AbbVie Stock Falls 11% in a Month: Should You Buy the Dip? - November 15, 2024 - Zacks.com

Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback - November 15, 2024 - Zacks.com

Wolfe starts AbbVie at Outperform, says valuation an attractive entry point

AbbVie Target of Unusually Large Options Trading (NYSE:ABBV)

Schulhoff & Co. Inc. Has $5.49 Million Position in AbbVie Inc. (NYSE:ABBV)

Sargent Investment Group LLC Boosts Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Metis Global Partners LLC

ING Groep NV Sells 96,568 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Trading Down 0.5% on Analyst Downgrade

Profits fall by 27% at Abbvie's Botox plant at Westport

Hourglass Capital LLC Sells 31,165 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Bell Bank

AbbVie (NYSE:ABBV) Trading Up 0.1% - Time to Buy?

Oppenheimer & Co. Inc. Has $29.38 Million Position in AbbVie Inc. (NYSE:ABBV)

Souders Financial Advisors Purchases 416 Shares of AbbVie Inc. (NYSE:ABBV)

JPMorgan Chase & Co. Issues Pessimistic Forecast for AbbVie (NYSE:ABBV) Stock Price

Saturna Capital Corp Purchases 560,808 Shares of AbbVie Inc. (NYSE:ABBV)

Pinnacle Financial Partners Inc Buys 4,441 Shares of AbbVie Inc. (NYSE:ABBV)

Aigen Investment Management LP Invests $1.21 Million in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Trading Up 0.5% - Here's Why

Carrera Capital Advisors Increases Position in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Price Target Lowered to $215.00 at Citigroup

BMO Capital Markets Issues Pessimistic Forecast for AbbVie (NYSE:ABBV) Stock Price

Victory Capital Management Inc. Sells 166,072 Shares of AbbVie Inc. (NYSE:ABBV)

Aptus Capital Advisors LLC Buys 14,457 Shares of AbbVie Inc. (NYSE:ABBV)

Health Monitor Network Expands Leadership Team in Response to Continued Growth | Taiwan News | Nov. 12, 2024 23:51

MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K

Nasdaq futures decline, Nvidia shares dip following the earnings report

Markets Mixed Amid Inflation, Tech Rally, and UK Economic Woes

Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024

Bitcoin price hits record high over $93,800 as Trump rally resumes

Gold Shines, Bitcoin Surges, and Nvidia Earnings in Focus

What is the cryptocurrency market doing: Musk's DOGE Role Boosts Dogecoin

Bitcoin price prediction: BTC May Reach $100K Before New Year